QNCX QNCX

Quince Therapeutics Share Price - QNCX

1.33
0.00 (0.0%)
1.33
Volume 0
Bid Price 1.21
Ask Price 1.45
News -
Day High

Low
1.20

52 Week Range

High
98.50

Day Low
Stock Name Stock Symbol Market Stock Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 1.33 05:02:23
Open Price Low Price High Price Close Price Previous Close
1.33
Trades Stocks Traded Average Volume 52 Week Range
0 0 - 1.20 - 98.50
Last Trade Type Quantity Price Currency
- 0 US$ 1.33 USD

Period:

Draw Mode:

Quince Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 48.02M 36.10M 25.44M US$ - US$ - -3.03 -0.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - - 382.05k 6.90%

more financials information »

Quince Therapeutics News

Date Time Source News Article
9/16/202207:00Business WireQuince Therapeutics Presents Preclinical Data at MHSRS 2022..
9/12/202207:00Business WireQuince Therapeutics Presents Preclinical Data at ASBMR 2022..
9/08/202216:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/30/202215:05Business WireQuince Therapeutics Presents Preclinical Data at OI 2022..
8/25/202215:05Business WireQuince Therapeutics to Present at Upcoming Scientific..
8/09/202215:28Edgar (US Regulatory)Quarterly Report (10-q)
8/04/202207:00Business WireQuince Therapeutics to Present at Canaccord Genuity 42nd..
8/01/202208:17Edgar (US Regulatory)Current Report Filing (8-k)
7/27/202207:01Business WireCortexyme Corporate Name Change to Quince Therapeutics to..
7/27/202207:00Business WireCortexyme Successfully Completes Phase 1 Single and Multiple..
7/22/202215:26Edgar (US Regulatory)Current Report Filing (8-k)
7/08/202211:57Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QNCX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.291.461.201.33173,4860.043.1%
1 Month1.641.75761.201.47215,721-0.31-18.9%
3 Months2.472.71711.201.89248,663-1.14-46.15%
6 Months6.776.801.202.81374,595-5.44-80.35%
1 Year96.2398.501.2012.14960,829-94.90-98.62%
3 Years22.80121.981.2023.13443,126-21.47-94.17%
5 Years20.00121.981.2023.30400,919-18.67-93.35%

Quince Therapeutics Description

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.
Your Recent History
NASDAQ
QNCX
Quince The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221003 10:25:07